AI assistant
REPLIGEN CORP — Director's Dealing 2022
Mar 3, 2022
30826_dirs_2022-03-02_d4345775-c3b1-4545-80b3-262e32a00f33.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2022-02-27
Reporting Person: KURIYEL RALF (Senior VP, R&D)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-02-27 | Common Stock | F | 477 | $196.70 | Disposed | 18645 | Direct |
| 2022-02-28 | Common Stock | F | 473 | $196.70 | Disposed | 18172 | Direct |
| 2022-02-28 | Common Stock | A | 4234 | $0.00 | Acquired | 22406 | Direct |
| 2022-02-28 | Common Stock | F | 1584 | $196.70 | Disposed | 20822 | Direct |
Footnotes
F1: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.
F2: Represents shares issued pursuant to a Performance Stock Unit ("PSU") award granted to the Issuer on February 28, 2019. The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria set forth in the PSU award.
F3: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the settlement of the PSUs.